Register of Telaprevir and Boceprevir in Routine Clinical Practice

Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia

NCT02511496 ·Status: UNKNOWN

Telaprevir Open-Label Study in Co-Infected Patients

NCT01500616 ·Status: COMPLETED ·Phase: PHASE3

Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

NCT01508286 ·Status: NO_LONGER_AVAILABLE

A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)

NCT01756079 ·Status: COMPLETED ·Phase: PHASE4

Virology Follow up Study in Subjects Previously Treated With Telaprevir

NCT00916474 ·Status: COMPLETED

A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

NCT01591460 ·Status: COMPLETED ·Phase: PHASE4

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

NCT01577069 ·Status: COMPLETED

Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir

NCT01465516 ·Status: TERMINATED

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

NCT03111966 ·Status: COMPLETED

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection

NCT00580801 ·Status: COMPLETED ·Phase: PHASE2

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

NCT01980290 ·Status: COMPLETED

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

NCT00530972 ·Status: COMPLETED ·Phase: PHASE4

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

NCT00301509 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation

NCT01463956 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

NCT02333292 ·Status: COMPLETED

Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection

NCT01771653 ·Status: COMPLETED

Telaprevir in Genotype 3 HCV

NCT02087111 ·Status: COMPLETED ·Phase: PHASE4

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

NCT01884402 ·Status: COMPLETED

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

NCT01571583 ·Status: COMPLETED ·Phase: PHASE3

Long Term Follow-up of Hepatitis C Cured Patients

NCT03246048 ·Status: COMPLETED

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

NCT00758043 ·Status: COMPLETED ·Phase: PHASE3

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

NCT02196064 ·Status: COMPLETED

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

NCT01222611 ·Status: COMPLETED ·Phase: PHASE4

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

NCT02060058 ·Status: COMPLETED ·Phase: PHASE3

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

NCT01335529 ·Status: COMPLETED ·Phase: PHASE2